N/A
N=106
Goal2QuitVaping for Nicotine Vaping Cessation Among Adolescents
Depressive Symptoms · Depression · Adolescent Behavior
Bottom Line
View on ClinicalTrials.gov: NCT04951193 ↗Enrolled (actual)
106
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcome: Primary: Mean Score of Depressive Symptoms — -9.50; -8.30 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Behavioral Activation Therapy app (Behavioral); Treatment as Usual (Behavioral)
- Age
- Pediatric, Adult · 16+ yrs
- Sex
- All
- Sponsor
- Medical University of South Carolina
- Primary completion
- May 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Score of Depressive Symptoms |
-9.50; -8.30 | — |
| PRIMARY Average Vapes Per Day at Week 4 |
9.42; 10.17 | — |
| PRIMARY E-cigarette Dependence |
-2.19; -2.38 | — |
| PRIMARY Number/Duration of Quit Attempts |
5.00; 4.00 | — |
| PRIMARY 7-day Point Prevalence Abstinence |
14; 15 | — |
Summary
The purpose of this study is to evaluate a mobile application (app) called "Goal2QuitVaping" to help adolescents quit vaping nicotine. Goal2QuitVaping was developed by our research team to assist with quitting vaping. Participants will be randomly assigned to either download the mobile app, "Goal2QuitVaping", or not. If provided with Goal2QuitVaping, participants will be asked to use the app regularly, at least once per day, throughout the study duration. Participants will be asked to complete electronic questionnaire measures throughout the study period. Participation in this study will take about 4 weeks.
Eligibility Criteria
Inclusion Criteria
- age 16-20
- vaped nicotine on ≥20 days out of the last 30
- elevated depressive symptoms, defined as a score of ≥10 on Patient Health Questionnaire-8 (PHQ-8) during preliminary screening and the Adolescent Patient Health Questionnaire-9 (PHQ-9A) at final eligibility
- currently own an iOS or Android smartphone
- report willingness to utilize an app for quitting vaping nicotine (response of "yes" on yes/no item)
- have a valid e-mail address that is checked regularly or regular access to text messages (for follow-up assessments)
- ability to read the consent form
- has been seen (in person or remotely) by a primary care physician within the last year
Exclusion Criteria
- smoked cigarettes or used other tobacco products on ≥9 days out of the last 30
- severe visual impairment
- currently receiving treatment for vaping or tobacco use
- current suicidal ideation, defined as a response ≥1 on item nine of the PHQ-9A or ≥2 on item 9 of the BDI-II
- household member currently enrolled in the study
- inability to read the consent form
Data sourced from ClinicalTrials.gov (NCT04951193). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.